搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Mustela nivalis Cytochrome b (MT-CYB), partial CSB-YP864986MKAY
CSB-EP864986MKAY
CSB-BP864986MKAY
CSB-MP864986MKAY
CSB-EP864986MKAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arbacia lixula ATP synthase protein 8 (MT-ATP8), partial CSB-YP864987ANK
CSB-EP864987ANK
CSB-BP864987ANK
CSB-MP864987ANK
CSB-EP864987ANK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ophiophagus hannah Cytochrome b (MT-CYB), partial CSB-YP864988OEL
CSB-EP864988OEL
CSB-BP864988OEL
CSB-MP864988OEL
CSB-EP864988OEL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Laticauda colubrina Cytochrome b (MT-CYB), partial CSB-YP864989LCZ
CSB-EP864989LCZ
CSB-BP864989LCZ
CSB-MP864989LCZ
CSB-EP864989LCZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Micropechis ikaheka Cytochrome b (MT-CYB), partial CSB-YP864990MKAZ
CSB-EP864990MKAZ
CSB-BP864990MKAZ
CSB-MP864990MKAZ
CSB-EP864990MKAZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coluber constrictor Cytochrome b (MT-CYB), partial CSB-YP864991CNAO
CSB-EP864991CNAO
CSB-BP864991CNAO
CSB-MP864991CNAO
CSB-EP864991CNAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cervus elaphus hippelaphus ATP synthase protein 8 (MT-ATP8), partial CSB-YP864992CNAP
CSB-EP864992CNAP
CSB-BP864992CNAP
CSB-MP864992CNAP
CSB-EP864992CNAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Talpa europaea Cytochrome b (MT-CYB), partial CSB-YP864993TLA
CSB-EP864993TLA
CSB-BP864993TLA
CSB-MP864993TLA
CSB-EP864993TLA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cinnamomum camphora ATP synthase subunit beta, chloroplastic (atpB) CSB-YP864994CDAV
CSB-EP864994CDAV
CSB-BP864994CDAV
CSB-MP864994CDAV
CSB-EP864994CDAV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Photosystem II reaction center protein ycf12 (ycf12), partial CSB-YP864995EEAP
CSB-EP864995EEAP
CSB-BP864995EEAP
CSB-MP864995EEAP
CSB-EP864995EEAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Photosystem I reaction center subunit XII (psaM), partial CSB-YP864996EEAQ
CSB-EP864996EEAQ
CSB-BP864996EEAQ
CSB-MP864996EEAQ
CSB-EP864996EEAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Photosystem II reaction center protein K (psbK) CSB-YP864997PMAR
CSB-EP864997PMAR
CSB-BP864997PMAR
CSB-MP864997PMAR
CSB-EP864997PMAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Heterocapsa pygmaea Photosystem Q (B) protein (psbA), partial CSB-YP864998HGAG1
CSB-EP864998HGAG1
CSB-BP864998HGAG1
CSB-MP864998HGAG1
CSB-EP864998HGAG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sequoia sempervirens Maturase K (matK), partial CSB-YP864999SKAY
CSB-EP864999SKAY
CSB-BP864999SKAY
CSB-MP864999SKAY
CSB-EP864999SKAY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Averrhoa carambola Ribulose bisphosphate carboxylase large chain (rbcL) CSB-YP865000AKAR
CSB-EP865000AKAR
CSB-BP865000AKAR
CSB-MP865000AKAR
CSB-EP865000AKAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oenothera elata subsp. hookeri Cytochrome c biogenesis protein ccsA (ccsA), partial CSB-YP865001OAS1
CSB-EP865001OAS1
CSB-BP865001OAS1
CSB-MP865001OAS1
CSB-EP865001OAS1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oenothera elata subsp. hookeri 50S ribosomal protein L36, chloroplastic (rpl36) CSB-YP865002OAS
CSB-EP865002OAS
CSB-BP865002OAS
CSB-MP865002OAS
CSB-EP865002OAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oenothera elata subsp. hookeri 30S ribosomal protein S18, chloroplastic (rps18) CSB-YP865003OAS
CSB-EP865003OAS
CSB-BP865003OAS
CSB-MP865003OAS
CSB-EP865003OAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oenothera elata subsp. hookeri Photosystem I assembly protein Ycf4 (ycf4), partial CSB-YP865004OAS1
CSB-EP865004OAS1
CSB-BP865004OAS1
CSB-MP865004OAS1
CSB-EP865004OAS1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oenothera elata subsp. hookeri DNA-directed RNA polymerase subunit beta' (rpoC2), partial CSB-YP865005OAS
CSB-EP865005OAS
CSB-BP865005OAS
CSB-MP865005OAS
CSB-EP865005OAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>